Last reviewed · How we verify
DTP Vaccine at 9 months of age
DTP Vaccine at 9 months of age is a Biologic drug developed by Medical Research Council Unit, The Gambia. It is currently in Phase 1 development. Also known as: DTP.
At a glance
| Generic name | DTP Vaccine at 9 months of age |
|---|---|
| Also known as | DTP |
| Sponsor | Medical Research Council Unit, The Gambia |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DTP Vaccine at 9 months of age CI brief — competitive landscape report
- DTP Vaccine at 9 months of age updates RSS · CI watch RSS
- Medical Research Council Unit, The Gambia portfolio CI
Frequently asked questions about DTP Vaccine at 9 months of age
What is DTP Vaccine at 9 months of age?
DTP Vaccine at 9 months of age is a Biologic drug developed by Medical Research Council Unit, The Gambia.
Who makes DTP Vaccine at 9 months of age?
DTP Vaccine at 9 months of age is developed by Medical Research Council Unit, The Gambia (see full Medical Research Council Unit, The Gambia pipeline at /company/medical-research-council-unit-the-gambia).
Is DTP Vaccine at 9 months of age also known as anything else?
DTP Vaccine at 9 months of age is also known as DTP.
What development phase is DTP Vaccine at 9 months of age in?
DTP Vaccine at 9 months of age is in Phase 1.
Related
- Manufacturer: Medical Research Council Unit, The Gambia — full pipeline
- Also known as: DTP
- Compare: DTP Vaccine at 9 months of age vs similar drugs
- Pricing: DTP Vaccine at 9 months of age cost, discount & access